Integra LifeSciences
Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic
3rd FDA panel barely favors BSX’s Watchman | Regulatory news for the week of October 13, 2014
FDA OKs Integra Lifesciences Puerto Rico plant
Integra LifeSciences to pay $60M for Medtronic ENT instruments
COV shareholder sues to block pending MDT merger | Medtech legal news for the week of August 18, 2014
Ex-Integra sales rep, manager cop to $800k hospital fraud scheme
FDA OKs Integra LifeSciences foot bone wedges
Integra LifeSciences (NSDQ:IART) said it obtained 510(k) clearance from the FDA for its Integra titanium bone wedges.
The wedges are designed for corrective procedures, such as osteotomies, in treating fractures in foot bones, according to a press release.
Covidien closes $235M divestiture of Confluent to Integra LifeSciences
Covidien to unload Confluent Surgical to Integra for $235M
Integra Lifesciences gains after FDA OKs plant | Wall Street Beat
Integra LifeSciences (NSDQ:IART) shares are up today after the medical device company revealed that FDA inspectors yesterday cleared a New Jersey plant that was the subject of a 2011 warning letter.